Article
Fully searchable access to the August 1, 2009 issue
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%
3 Things You Should Know About Interventional Glaucoma Comanagement
Prevent Blindness declares July as Dry Eye Month
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Health Canada approves Biocon's Yesafili, biosimilar to Eylea
HLB Therapeutics misses primary end point in phase 3 SEER-3 trial of RGN-259